First human test: new Drug's safety checked
NCT ID NCT07134127
Summary
This was an early, first-in-human study to check the safety and basic effects of a single dose of a new drug called IBI3032. It involved 40 healthy volunteers and tested how the body processes the drug, including whether taking it with or without food makes a difference. The main goal was to see if the drug was safe and well-tolerated at different dose levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Frist Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230000, China
Conditions
Explore the condition pages connected to this study.